Diabetes
CRIAA's cell therapy technology can provide continuous insulin secretion, stabilizing blood glucose and reducing complications.

MMC Canada Research Institute of Anti-Aging
The innovative encapsulation device addresses key challenges such as immune rejection, precise localization, and tumor risk, enhancing both safety and effectiveness.
A semi-transparent material allows nutrient flow while blocking immune cells. AI-assisted controls enhance therapeutic efficacy.
Integrating MSC and IPSC strategies offers short-term competitive advantages while laying the groundwork for long-term innovation.
Real-time sensors enable precise treatment adjustments, minimizing risks and enhancing patient quality of life.
The device optimizes cell therapy by overcoming challenges such as immune rejection, precise localization, and inflammation.
AI-powered production processes enable large-scale, consistent manufacturing to meet clinical demands.
Our innovative stem cell therapies are designed to regenerate and repair damaged tissues, offering cutting-edge treatments for a range of conditions. From stabilizing blood glucose in diabetes to supporting weight loss and enhancing neurological function, our therapies provide a safer, more effective approach to improving health and quality of life.
CRIAA's cell therapy technology can provide continuous insulin secretion, stabilizing blood glucose and reducing complications.
Our GLP-1 cell delivery device aims to suppress appetite and regulate metabolism, providing a safer, more effective treatment for obesity.
Stem cell therapies can regenerate and repair damaged neural tissues, improving motor function and cognitive abilities.
Comprehensively enhance the body's vitality and delaying the aging process with our personalized anti-aging program.
Combining advanced cell delivery technology and cell therapy for functional repair or recovery.
